Herbs (Global Traditional) · Traditional Chinese Medicine
Kampo Ninjin (Panax ginseng) (Panax ginseng)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Kampo Ninjin (Panax ginseng) contains ginsenosides that modulate HPA axis function and cellular energy metabolism through adenylyl cyclase activation. This adaptogenic herb traditionally supports fatigue recovery and metabolic regulation in Japanese Kampo medicine.
Kampo Ninjin refers to Panax ginseng root, a perennial plant from the Araliaceae family native to East Asia, used in Japanese Kampo medicine. The roots are processed through traditional water decoction, steam distillation, ethanol extraction, or steaming/heating methods that transform ginsenosides into various bioactive compounds.
The research dossier lacks specific human clinical trials, RCTs, or meta-analyses for Kampo Ninjin alone, with no PubMed PMIDs provided. Evidence is limited to its inclusion in multi-ingredient Kampo formulas like Ninjinyoeito (NYT), though specific trial designs and outcomes for Ninjin are not detailed.
No clinically studied dosage ranges, standardized forms, or ginsenoside content specifications are available in the current research for Kampo Ninjin. Consult a healthcare provider before starting any new supplement.
Kampo Ninjin (Panax ginseng) root is not consumed as a macronutrient source but contains measurable bioactive and nutritional constituents. Macronutrient composition of dried root: carbohydrates approximately 60-70% dry weight (primarily starch, pectin, and polysaccharides including ginsenan PA, PB, and S-IIA), protein approximately 12-16% dry weight (including lectins and peptides), fat approximately 1-2% dry weight. Key bioactive compounds: ginsenosides (saponins) total concentration 2-3% dry weight in root, with major fractions including Rb1 (0.1-0.5%), Rg1 (0.1-0.4%), Rc, Rb2, Re, and Rd; panaxans (hypoglycemic polysaccharides) at approximately 0.5-1.2% dry weight; panaxynol and panaxydol (polyacetylenes) at trace concentrations (~0.01-0.05%); essential oils including beta-elemene and panacene at <0.05%. Micronutrients present in dried root: potassium approximately 500-700 mg/100g, calcium approximately 40-80 mg/100g, magnesium approximately 30-50 mg/100g, phosphorus approximately 100-150 mg/100g, iron approximately 2-5 mg/100g, zinc approximately 0.5-1.5 mg/100g. Vitamins: thiamine (B1) approximately 0.1 mg/100g, riboflavin (B2) approximately 0.3 mg/100g, niacin approximately 1-2 mg/100g; vitamin C present in fresh root at approximately 4-7 mg/100g but largely degraded during drying and processing. Fiber: approximately 8-12% dry weight as dietary fiber including pectins. Bioavailability notes: ginsenoside bioavailability is low orally (estimated 1-10%) due to poor intestinal absorption; gut microbiota convert ginsenosides Rb1 and Rc to more bioavailable compound K (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol), which shows significantly higher absorption; alcohol-based extraction (ethanol) substantially increases ginsenoside yield compared to aqueous decoction; polysaccharide fractions are largely non-absorbed and exert effects luminally or via gut microbiome modulation.
Ginsenosides Rb1, Rg1, and Re activate adenylyl cyclase and increase cAMP levels, enhancing cellular energy production. These compounds modulate the hypothalamic-pituitary-adrenal axis by influencing cortisol release and glucocorticoid receptor sensitivity. Ginsenosides also stimulate nitric oxide synthase activity, improving vascular function and nutrient delivery.
Most evidence for Kampo Ninjin comes from traditional use documentation rather than controlled trials. Small observational studies of Ninjinyoeito formulas (containing 3-6g Panax ginseng) showed modest improvements in fatigue scores and quality of life measures in elderly populations. Limited pharmacokinetic studies indicate ginsenoside bioavailability varies significantly between individuals. The evidence base remains primarily traditional with limited modern clinical validation.
Kampo Ninjin may cause insomnia, headaches, and digestive upset, particularly at doses above 3g daily. It can enhance the effects of stimulant medications and may interfere with warfarin metabolism through CYP2C9 inhibition. Contraindicated in pregnancy due to potential estrogenic effects of ginsenosides. May exacerbate hypertension and should be used cautiously with diabetes medications due to blood sugar effects.
